Table 1.
APOE-E4 genotype | |||
---|---|---|---|
|
|||
No | YES | P. | |
Baseline cognitive function | .39 | .33 | <.138 |
Follow-up cognitive function | −.01 | −.24 | <.0001 |
Change in cognitive function | −.40 | −.58 | <.0001 |
Age (baseline) | 74.71 | 73.38 | <.0001 |
Sex (male) | .38 | .40 | <.419 |
Black | .48 | .58 | <.001 |
Education (baseline) | 12.74 | 12.72 | <.899 |
Duration of residence | 32.61 | 32.14 | <.633 |
Follow-up time | 9.11 | 9.01 | <.623 |
Neighborhood disorder | −.02 | .02 | <.001 |
Neighborhood disadvantage | −.07 | .12 | <.001 |
Note: Data come from the Chicago Health and Aging Project. Cell entries represent unweighted descriptive statistics (means for continuous variables and proportions for categorical variables). Neighborhood-level means and standard deviations are based on observations nested within 20 census tracts. There was anaverage of 103.2 respondents per neighborhood (SD = 44.9) with a minimum of 22 and a maximum of 206.